MedPath

Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

Recruiting
Conditions
Tricuspid Valve Regurgitation; Complications, Longterm Outcome
Interventions
Procedure: Huanlei Huang
Registration Number
NCT06554119
Lead Sponsor
Guangdong Provincial People's Hospital
Brief Summary

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
375
Inclusion Criteria

patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion Criteria

age <16,severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TVPHuanlei Huangtricuspid valvuloplasty group
TVRHuanlei Huangtricuspid valve replacement group,
Primary Outcome Measures
NameTimeMethod
death rate1999-01 - 2025-01

perioperative and longterm

complications1999-01 - 2025-01

perioperative and longterm complications

Secondary Outcome Measures
NameTimeMethod
redo of tricuspid valve1999-01 - 2025-01

redo of tricuspid valve during the follow-up

Trial Locations

Locations (1)

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath